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Endophenotype Network Models: 
Common Core of Complex Diseases
Susan Dina Ghiassian1,2, Jörg Menche1,2,3, Daniel I. Chasman4, Franco Giulianini5, 
Ruisheng Wang6, Piero Ricchiuto7, Masanori Aikawa7, Hiroshi Iwata7, Christian Müller8,9, 
Tania Zeller8,9, Amitabh Sharma1,2,10, Philipp Wild9,11,12, Karl Lackner9,13, Sasha Singh7, 
Paul M. Ridker4, Stefan Blankenberg8,9, Albert-László Barabási1,2,3,10,14 & Joseph Loscalzo6
Historically, human diseases have been differentiated and categorized based on the organ system in 
which they primarily manifest. Recently, an alternative view is emerging that emphasizes that different 
diseases often have common underlying mechanisms and shared intermediate pathophenotypes, 
or endo(pheno)types. Within this framework, a specific disease’s expression is a consequence of the 
interplay between the relevant endophenotypes and their local, organ-based environment. Important 
examples of such endophenotypes are inflammation, fibrosis, and thrombosis and their essential 
roles in many developing diseases. In this study, we construct endophenotype network models and 
explore their relation to different diseases in general and to cardiovascular diseases in particular. We 
identify the local neighborhoods (module) within the interconnected map of molecular components, 
i.e., the subnetworks of the human interactome that represent the inflammasome, thrombosome, 
and fibrosome. We find that these neighborhoods are highly overlapping and significantly enriched 
with disease-associated genes. In particular they are also enriched with differentially expressed genes 
linked to cardiovascular disease (risk). Finally, using proteomic data, we explore how macrophage 
activation contributes to our understanding of inflammatory processes and responses. The results of 
our analysis show that inflammatory responses initiate from within the cross-talk of the three identified 
endophenotypic modules.
A limited number of key endophenotypes are common to all diseases. Most notable among them are inflamma-
tion, thrombosis, and fibrosis1. These endophenotypes reflect mechanisms that facilitate the organism’s adapta-
tion to injury. Each has acute and resolving phases. The common goal of these underlying responses is to restore 
normal organ and organism function. In as much as these endophenotypes evolved to promote healing from 
acute injury, their implications for chronic injury or disease likely had a lesser role, if any, on their genetic selec-
tion. As a result, chronic overexuberant inflammatory, thrombotic, or fibrotic responses can yield organ impair-
ment and adverse long-term effects that outweigh the acute benefits they provide2–5.
Inflammation, thrombosis, and fibrosis are pathologically linked6: inflammation can induce (accelerate) 
thrombosis, thrombosis can induce inflammation7,8, and fibrosis can result from resolving inflammation and 
thrombosis9. For these reasons, we explored the joint molecular network determinants of these endophenotypes, 
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in particular aiming to identify those molecular subnetworks or mediators that are common to all, as well as those 
that are distinctive for each. In this way, we can define the determinants of the interplay among these common 
endophenotypes, as well as the determinants of heightened or deficient responses in them.
A complex cascade of molecular interactions occurs during inflammatory, thrombotic, and fibrotic processes, 
many of which remain poorly understood. Several molecules and cell types play a crucial role in these processes 
and exert their function through a network of interactions. Therefore, in this study we explore (a) network models 
of inflammation, thrombosis, and fibrosis; (b) their biological and topological crosstalk; and (c) the role of mac-
rophages as central cellular mediators of these endophenotypes.
Results
Constructing the inflammasome, thrombosome, and fibrosome. We start our analysis by assem-
bling a set of genes with established association (seed genes) with inflammation, thrombosis, and fibrosis from the 
literature (see Methods). In order to obtain genes with high-confidence association, we used two filtering criteria: 
(a) genes whose association has been reported in at least two publications; and (b) genes that are expressed in 
tissues related to cardiovascular diseases. The final numbers of seed genes for inflammation, thrombosis, and 
fibrosis were 456, 158, and 104, respectively (Table 1). As expected, the three gene sets show significant overlap; 
for example, 80% (p-value = 1.50 × 10−161; Fisher’s exact test) and 78% (p-value = 3.58 × 10−104) of the genes asso-
ciated with thrombosis and fibrosis, respectively, are also associated with inflammation (Fig. 1A). The list of seed 
genes is available in Data file S1.
For an independent biological evaluation of the compiled seed gene lists, we tested for association between 
candidate functional single nucleotide polymorphisms (SNPs) mapping to each seed gene and selected estab-
lished cardiovascular biomarkers, C-reactive protein (CRP), fibrinogen, soluble intercellular adhesion mole-
cule (ICAM), as well as a clinical vascular pathophenotype, venous thromboembolism (VTE) (see Methods and 
Endo-phenotype
#HuGENet 
genes
# Seed 
Genes
# Seed 
Genes 
in HI
LCC 
size z-score
Inflammation 1679 456 442 360 10.85
Thrombosis 603 158 156 96 19.25
Fibrosis 621 104 101 55 22.27
Table 1.  Genes associated with endo-phenotypes, on the human interactome.
Figure 1. Topological characteristics of seed genes within the Human Interactome. (A) Venn diagram of 
inflammatory (red), thrombotic (blue), and fibrotic (orange) seed genes. (B–D) correspond to subgraphs of the 
human interactome containing inflammatory, thrombotic, and fibrotic seed genes, respectively. These genes 
form a giant connected component, suggesting the existence of a local network neighborhood enriched with 
inflammatory, thrombotic, and fibrotic genes. The randomized distribution of the LCC size is shown in the 
histograms. For the effect of literature bias, see SI.
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Supplementary Fig. 1). Although curated seed genes are not necessarily expected to overlap with genetic associa-
tions meeting genome-wide significance (P-value < 5 × 10−8), we observed that for all four validation sets (CRP, 
fibrinogen, ICAM and VTE), inflammation and thrombosis seed genes carry a larger fraction of low p-value as 
compared to other genes in the network. We observed a similar effect for fibrosis seed genes with respect to CRP, 
ICAM, and VTE, but not fibrinogen (Supplementary Fig. 1).
To identify the sub-networks corresponding to the three endophenotypes, we compiled the human interac-
tome (HI) from several data sets containing physical binary interactions among molecular components. These 
datasets include regulatory, binary, kinase-substrate, metabolic, liver-specific, and protein complex-based inter-
actions (see Supplementary Material). The final HI consisted of N = 13,681 proteins (nodes) and M = 144,414 
interactions between them (edges).
Considerable evidence suggests that genes associated with complex diseases are not randomly scattered within 
the HI but tend to interact with each other in specific network neighborhoods, or disease modules10–12. The same 
phenomenon is found for the seed genes of the three endophenotypes: their seed genes form connected sub-
graphs whose sizes are significantly larger than expected by chance for randomly distributed genes (Fig. 1B–D 
and Table 1). To estimate the extent to which literature biases in our HI may be responsible for the observed 
clustering, we repeated the analysis using a high-throughput (yeast two-hybrid) interactome, and confirmed 
that the observed clustering, indeed, reflects the existence of modules responsible for these endophenotypes (see 
Supplementary Material effects of biased studies in the Human Interactome on disease gene clustering).
We used the seed gene clusters in the interactome as a starting point to explore the molecular mechanisms 
of the respective endophenotypes in the broader context of disease-associated endophenotype modules, i.e., 
sub-networks associated with inflammation, thrombosis, and fibrosis. To identify these neighborhoods of endo-
phenotype proteins, we used the DIseAse MOdule Detection (DIAMOnD) method that iteratively expands the 
seed gene neighborhood by adding proteins with a significant number of connections to the seed gene pool12. In 
principle, the method ranks all proteins in the network. To identify the boundary of each endophenotype module, 
we, therefore, considered their biological relevance with additional biological evidence (see Methods). We found 
that approximately the first 450, 700, and 650 DIAMOnD genes show a clear and significant biological association 
Figure 2. Biological validation of the detected DIAMOnD genes. Panels correspond to validating DIAMOnD 
genes of inflammation (A), thrombosis (B), and fibrosis (C), respectively (red lines, seed genes; green lines, 
DIAMOnD genes; black lines, randomly selected genes). Validation is assessed with respect to GeneOntology 
and MSIgDB pathways. As the DIAMOnD genes are iteratively added to the neighborhood, the p-value of 
enrichment increases with a clear jump to non-significant values (p-value ~ 1) at the indicated iteration. 
Therefore, we use the suggested iteration steps to define cutoffs for the methodology, and thereby identify the 
size limit of the underlying associated module. We chose 450, 700, and 600 first identified DIAMOnD nodes 
to form the inflammasome, thrombosome, and fibrosome modules, respectively. (D) Venn diagram of the 
inflammasome, thrombosome, and fibrosome genes. The fully embedded pathways within detected modules 
have been found in inflammasome-specific proteins, thrombosome-specific proteins, overlapping proteins in 
the inflammasome and thrombosome, and overlapping proteins in all three modules.
www.nature.com/scientificreports/
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with inflammatory, thrombotic, and fibrotic seed genes, respectively (Fig. 2A–C). DIAMOnD genes, together with 
the seed genes, form three endophenotype modules that we call the inflammasome, thrombosome, and fibrosome, 
containing 902, 858, and 704 proteins, respectively. Moreover, through the addition of 450 DIAMOnD proteins, 
93% of inflammatory seed proteins are integrated into a connected component (LCC) (Fig. 3A). Therefore, the 
additional DIAMOnD proteins allow for the integration of previously disconnected seed proteins into the (larg-
est) connected component of the modules. The resulting modules are robust towards small variations in the initial 
seed gene set. DIAMOnD methodology predicts a robust outcome with almost complete overlap when removing 
a random gene from the original set of seeds (Supplementary Fig. 2, see SI for details on the N-1 analysis).
The three modules have a large common core of 530 proteins (Fig. 2D). The thrombosome and inflammasome 
show significant (p-value < 10−324; see Methods) overlap of 637 genes (Jaccard index J = 0.57). This region could 
be further investigated for inflammation-induced thrombotic pathways13 . It is known, for example, that inflam-
mation inhibits natural anticoagulant pathways and fibrinolytic activity as well as increases procoagulant factors, 
thereby increasing the (net) thrombotic response.
Interestingly, the overlap between the modules is more significant than the overlap between the seed genes, 
suggesting that these endophenotypes are truly in the same neighborhood of the interactome. Further pathway 
analysis of the genes within the modules identified five fully embedded pathways: IL6, IGF1, extrinsic prothrom-
bin activation, AP1 family of transcription factors, and PECAM1. The pathways presented are exclusive to the 
region shown. In other words, the figure represents two pathways enriched in the overlap of three modules, as 
well as an inflammation-specific pathway, a thrombosis-specific pathway, and one pathway enriched in a region 
common to the inflammasome and thrombosome (Fig. 2D, Supplementary Table 1).
The role of endophenotype modules in cardiovascular disease risk and other complex diseases. 
We next turned to an analysis of the identified modules with respect to (a) cardiovascular disease risk (an example 
of preclinical disease), and (b) their more general association with complex diseases.
To assess the potential role of the three endophenotypes for the risk of developing cardiovascular diseases, we 
analyzed gene expression data in monocytes from a cohort of 1,258 individuals14,15 (see Methods), comparing 
individuals at high risk of cardiovascular diseases (cases) to patients at low risk (controls). Quantitative bio-
chemical risk factors measured in the population included CRP, fibrinogen, high-density lipoprotein cholesterol 
(HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein-A (APO-A), apolipoprotein-B (APO-B), 
and triglycerides (see Methods). We found that the respective sets of differentially expressed genes exhibit a 
significant overlap with each other (Supplementary Fig. 3). All three endophenotypes are strongly enriched with 
CRP, HDL, and APO-A-associated genes, which affirms the results of a previous proteomics study reflecting the 
link between HDL and inflammation16. The inflammasome and thrombosome were additionally enriched with 
triglyceride-related genes (Fig. 3B, Supplementary Table 2). The link of lipid-associated genes with thrombosis 
confirms prior work17.
For a more general assessment of the role of the three endophenotypes in complex diseases other than car-
diovascular diseases, we next analyzed their enrichment with disease proteins from a corpus of 299 diseases18. 
We found that, in total, the disease-genes associated with 156 (52% of) diseases significantly overlap with at 
least one of the three detected modules (Supplementary Table 3). Among these diseases, 67 are enriched in all 
three modules, while 11, 10 and 26 are inflammasome-, thrombosome-, and fibrosome–specific, respectively 
(Supplementary Table 4). These data support the notion that inflammation, thrombosis, and fibrosis are pathobi-
ological endophenotypes common to many diseases.
In summary, we observed that the three detected endophenotype modules are highly enriched with known dis-
ease genes, in general, and, more specifically, with differentially expressed genes associated with cardiovascular risk 
factors. Hence, the detected subregions of the network, including the proteins and their intermolecular interactions, 
are likely to be of high biological importance and worth analyzing in the context of disease development.
Figure 3. Topological properties and robustness of the endophenotypic modules. (A) Previously 
disconnected seed genes are now connected to each other through detected DIAMOnD genes. The 
inflammasome, thrombosome, and fibrosome modules so-constructed allow 93%, 90%, and 83% of seed 
genes to become part of the LCC, respectively. (B) Enrichment of seed genes and modules with differentially 
expressed genes in subjects with a significant cardiovascular risk factor burden.
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Topological properties of the endophenotype modules (central location of inflammatory and 
fibrotic genes). Prompted by the strong enrichment of the endophenotype modules with genes associated 
with complex diseases and preclinical cardiovascular disease (cardiovascular risk factors), we explored whether 
this central role is also reflected in specific topological properties of the modules within the interactome.
To do so, we analyzed the extent to which the robustness and structural integrity of the network depend on 
these proteins using a “tree” analysis (see Methods), i.e., testing whether a set of nodes constitutes an essen-
tial backbone of the HI (“trunk” of the tree) or whether it is of secondary importance for the overall struc-
ture (“leaves”) (Supplementary Fig. 4). The results of this analysis on both seeds and module proteins show that 
inflammatory seeds and modules as well as the fibrosome are trunk-like and, thus, essential for the overall integ-
rity of the network (with high z-score(CC) and z-score(LCC)) (Fig. 4A–D,G). Note that these results cannot be 
attributed to high average degree and centrality alone. Furthermore, despite having higher average degree and 
betweenness centrality, thrombosis and fibrotic seed proteins are not trunk-like (Fig. 4). See supplementary mate-
rial for a list of basic topological properties of these modules (Supplementary Table 5).
It is worth noting that thrombosis and fibrosis seeds are near-subsets of the inflammation seeds, i.e., ~80% of 
the seeds are inflammatory. However, only inflammation seeds are trunk-like. Similarly, although the inflammas-
ome and thrombosome overlap significantly and are comparable in size, only the inflammasome shows trunk-like 
behavior. These notable distinctions (a) exclude the possibility that size might be responsible for this effect, and 
(b) indicate that the non-overlapping proteins are responsible for the observed differences in essentiality. Overall, 
we conclude that the enrichment of the inflammasome with different disease determinants is rooted in its topo-
logically centered location within the HI.
Functionality of detected endophenotype modules using macrophages. During inflamma-
tory responses, monocytes differentiate into macrophages19, which appear to be a heterogeneous popula-
tion. Differences among macrophage subpopulations reflect their gene expression pattern, protein levels, and 
functions. M(IFNγ ) or M1 macrophages may play a key role in the acute phase of inflammation through the 
production of injurious molecules, whereas M(IL-4) or M2 cells may participate in tissue repair in a later phase.
Accumulating evidence from the literature suggests a role for pro-inflammatory macrophages in various 
aspects and stages of the development of cardiovascular diseases20,21. Several lines of evidence in humans have 
clearly associated the dominance of M1-like macrophages or activated circulating monocytes with cardiovascular 
risk factors [e.g., hyperlipidemia, diabetes22,23], plaque phenotype [e.g., unstable plaque24,25], or clinical events. 
The activated macrophage phenotype has typically been gauged by production of pro-inflammatory cytokines 
and chemokines, which IFNα typically induce in THP-1 cells26.
Figure 4. Tree analysis of seed genes and modules. Panels (A) through (F) show the observed size of the 
LCC and the number of connected components after removing the denoted gene sets. The observed parameter 
is compared to that of random expectation and a z-score is calculated. Panel G shows the phase diagram of 
z-score(CC) and z-score(LCC) of inflammation-, thrombosis-, and fibrosis-associated genes. As shown, the 
inflammasome, thrombosome, and fibrosome, as well as inflammatory seed genes, are highly essential for 
defining the clustered structure of the network.
www.nature.com/scientificreports/
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In order to identify proteins that play a role in pro-inflammatory27,28 responses, we used two unbiased quan-
titative proteomic datasets generated from human THP-1 macrophage-like cells without (M0 (untreated)) or 
stimulated with INFγ (M(IFNγ ) or M129. Proteins were sampled at six time points up to 72 hours of stimulation 
(see Methods for data description and analysis). This experimental procedure yields a time series of protein abun-
dance that can inform or suggest downstream causation (Fig. 5A).
There were 3,821 proteins with at least one interacting partner in the HI detected in both M1 and the baseline 
control, M0. Among these proteins, 447 overlap with endophenotype modules (p-value = 1.40 × 10−15). We refer 
to these 447 proteins as “ome-M1” proteins, indicating the detected proteins in both M0 and M1 that overlap 
with the three endophenotype modules, the inflammasome, the thrombosome, and the fibrosome. We observed 
that the functional annotations of the ome-M1 proteins differ significantly from the rest of the detected proteins 
(Supplementary Fig. 5, see Methods).
As we are interested in finding proteins responsive to inflammatory stimuli, we studied the proteins’ abun-
dance in M1 relative to M0 (where proteins are not induced and their abundance varies normally). Therefore, 
we first calculated the fold change of protein abundances at each time point. We did this by dividing the protein 
abundances in M1 by M0. Next, we identified subgroups of enhanced and suppressed proteins by applying a 
k-means clustering on the time series of fold changes for ome-M1 proteins (See Methods). The changes in sum of 
within-cluster distances (sw) of protein levels with respect to the number of clusters suggests k = 5 clusters as an 
optimal number of clusters (Fig. 5B, elbow method). The first (last) identified cluster represents a set of proteins 
with high (low) relative abundance throughout the measurement time (Fig. 5C). Cluster 2 represents a subset of 
proteins in which protein abundance is higher than the M0 baseline during the first day and decreases thereafter. 
At the same time, clusters 3 and 4 together represent two subsets of proteins that are highly expressed only after 
the first day of activation with IFNγ. We refer to these two subgroups as early and late proteins where early pro-
teins have an elevated relative abundance within the first days and decreased levels thereafter, and late proteins are 
unaffected within the first day and increase their expression after 24 hrs.
This observation suggests that the high abundance of early proteins on the first day is mechanistically linked 
to the abundance of late proteins. This observation is also consistent with the connectivity patterns among early 
and late proteins within the interactome: Each late or early protein has kin interactions with the other proteins 
within its own group and kout interactions with the proteins of the other group. We find that early proteins tend 
to interact with late proteins more than they do with themselves. In contrast, late proteins tend to interact with 
each other more than they interact with early proteins. An early protein has an average kin of 3.33 and an average 
kout of 8.24, whereas a late protein has an average kin of 9.71 and an average kout of 4.71. This observation suggests 
that early proteins are responsible for triggering late proteins, while downstream, triggered late proteins tend to 
interact with each other.
Figure 5. Detecting early and late proteins of inflammatory responses. (A) Schematic representation of 
inducing inflammatory stimulator to THP1 cells. (B) Sum of within cluster distances vs. number of clusters 
where k = 5 was found to detect optimal clustering. (C) Clusters formed by k-means clustering analysis of M1 
macrophages where two boxes indicate late and early expressed protein. (D) Network representation of early 
and late proteins within detected endophenotype modules and the enrichment of early proteins within cross-
talk region of the three endophenotypic modules.
www.nature.com/scientificreports/
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To define a high confidence set of early and late proteins, we compared the average abundance levels of pro-
teins within and after the first 24 hrs (Fig. 5D) and selected those that satisfy three different confidence criteria 
(See Methods for more details). Early and late proteins, while separated, are interconnected within the modules 
and, thus, directly influence each other. A list of the top 20 pathways enriched by early and late proteins charac-
terized by the most stringent confidence criterion (See Methods) can be found in Table 2. Supplementary Tables 
6 and 7 list the same properties for proteins characterized by less stringent criteria. These early and late proteins 
are interconnected within the modules (Fig. 5E) and, thus, likely affect each other. That they do so is supported 
by a thorough review of the 33 early proteins and 18 late proteins in Table 2 for those for which there is litera-
ture evidence of a mechanistic association as a validation of the network approach. Among the early proteins, 
a minority–i.e., five–show mechanistic (binding or pathway-dependent) links to the triggering of late protein 
expression by published experimental evidence. These include CARD9, which can trigger IL1B30 and CASP731; 
PARP1, which can induce NAMPT32 and TRADD33; CD36, which can trigger IRAK134; PRKDC, which can 
induce NAMPT35; and HSPB1, which can also induce TRADD36. Interestingly, the induction of CASP7 can lead 
to a reduction in PARP137. The interrelationships between early and late proteins of pathways that affect inter-
leukin signaling, TNF signaling, NAD synthesis, and caspase activation are clear from this analysis and highlight 
those molecular features conventionally viewed as ‘inflammatory’ as central to late-appearing protein responses 
that also play a key role in thrombosis and fibrosis.
Unlike late proteins, early proteins are significantly located within the area of overlap among the throm-
bosome, inflammasome, and fibrosome modules (p-value = 0.01) (Fig. 5E). This finding suggests that an early 
core response common to all endophenotypes disseminates throughout the endophenotype network to the more 
distinct endophenotypes at later times. A list of all genes in the cross-talk region is provided in a Data file S2.
Discussion
Beginning with high confidence literature-curated seed genes and using the DIAMOnD methodology, we 
detected three sub-regions within the HI associated with inflammatory, thrombotic, and fibrotic responses. These 
highly overlapping regions are significantly enriched with several disease determinants, including: (a) disease 
genes associated with more than 50% of the compiled complex diseases, and (b) differentially expressed genes 
associated with cardiovascular risk factors (i.e., preclinical disease). Separately, we found IL6, IGF1, extrinsic pro-
thrombin activation, the AP1 family of transcription factors, and PECAM1 pathways to be fully embedded within 
these modules. The three endophenotypes are not only of interest in terms of functional enrichment, but also lie 
within a topologically important region of the HI. We showed that proteins belonging to the inflammasome and 
fibrosome are highly essential for maintaining the overall structure and integrity of the network.
To study further the rather large number of proteins in the predicted modules, we dissected them into func-
tional subgroups. As proteins function through a cascade of interactions among cellular components, it is impor-
tant to be able to map this biological and topological information to a potential molecular mechanism and find 
the most relevant underlying pathways. We, therefore, divided the genes within the modules into different sub-
groups, each of which having a certain role in inflammatory processes. These subgroups are defined based on the 
protein clusters with similar expression pattern towards the inflammatory cytokine (INFγ ). Detailed analysis of 
module response to INFγ led us to observe four significantly distinctive protein abundance patterns belonging to: 
(a) expressed proteins, (b) silent proteins, (c) early proteins, and (d) late proteins. Present (silent) proteins show 
an elevated (decreased) level of abundance throughout the course of 72 hrs after INFγ exposure. Early proteins 
manifest an elevated abundance during the first day, while late proteins show low abundance during the first 
day and are increased in abundance thereafter. Our observations suggest that the common underlying mecha-
nism of many inflammatory-driven complex diseases resides in the common core of the endophenotype modules 
detected in this work.
We studied the obvious limitations of the interpretations drawn from our observations, such as the biased and 
incomplete nature of the HI maps. Based on our analysis, the initial observations leading to the detection of the 
endophenotypic modules is robust and holds in unbiased maps, and, thus, are expected to improve with increas-
ing coverage of the existing maps. The endophenotypic modules as well as their region of cross-talk detected in 
this work merit more clinical attention in the context of the pathobiology and treatment of inflammatory-driven 
phenotypes.
In addition, the proteins within the detected regions and their interactions warrant further study in the search 
for proposing molecular mechanisms and candidate drug targets for specific diseases.
Methods
Curation of disease genes associated with inflammation, thrombosis, and fibrosis. We used 
HuGe Navigator (http://www.hugenavigator.net) to retrieve genes with established associations with inflamma-
tion, thrombosis, and fibrosis. HuGE Navigator is a continuously updated and publicly available knowledge base 
that retrieves genes associated with a phenotype of interest by first parsing PubMed articles and subsequently 
manually reviewing the results by experts.
Tissue specificity. To obtain disease-gene associations of higher confidence, we restricted the seed genes 
to those present in at least one cardiovascular disease-specific tissue using gene expression data from 79 human 
tissues38. The specific tissues considered include: monocytes, vascular smooth muscle cells, endothelial cells, 
T-cells, and hepatocytes. We consider a gene to be expressed in a tissue if its expression level in the healthy state 
meets one of the following criteria:
1. Expression level of 200 mRNA counts or higher in the specified tissue.
2. The expression level in the specified tissue is significantly higher than the expression profile across all tissues. 
www.nature.com/scientificreports/
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FC > 1.5 
p<0.05 Statistics Proteins Top 20 enriched pathways
Early proteins
#proteins = 33
M = 26
LCC size = 14
< k> = 81.03
< kin> = 1.57
< kout> = 0.64
pin, out = 0.01
STMN1, VAV3, ITGA3, CARD9, GNA12, 
IFNGR1, RASA1, PARP1, CD36, SCARB1, 
CSNK2A1, PTGS1, CD22, TNPO1, DHFR, 
PEBP1, GPX1, AKT2, PRKDC, CD9, LRPPRC, 
HSPB1, TOP2A, CLTC, CABIN1, CD58, CCNB1, 
CALM1, CDK1, CDK9, CDK7, CSK, RPS27A
REACTOME_HEMOSTASIS
REACTOME_FORMATION_OF_PLATELET_PLUG
BIOCARTA_PTC1_PATHWAY
BIOCARTA_SRCRPTP_PATHWAY
REACTOME_PLATELET_ACTIVATION
REACTOME_CYCLIN_A1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION
BIOCARTA_CELLCYCLE_PATHWAY
BIOCARTA_G2_PATHWAY
KEGG_HEMATOPOIETIC_CELL_LINEAGE
REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION
REACTOME_G1_S_TRANSITION
KEGG_CELL_CYCLE
REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_
FORMATION
KEGG_MAPK_SIGNALING_PATHWAY
REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES
REACTOME_PLATELET_ACTIVATION_TRIGGERS
BIOCARTA_HIVNEF_PATHWAY
BIOCARTA_AKAP95_PATHWAY
REACTOME_PHOSPHORYLATION_OF_THE_APC
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
Late proteins
LCC size = 5
M = 7
< k> = 64.22
< kin> = 0.78
< kout> = 1.17
pin, out = 0.24
TAB1, IL1RN, IL1B, NAMPT, VDAC1, NCF1, 
CTTN, RPS24, CD74, TANK, BIRC2, TRAF3, 
IRAK1, TRADD, RANBP9, CRK, CASP7, NCF2
KEGG_LEISHMANIA_INFECTION
KEGG_APOPTOSIS
BIOCARTA_IL1R_PATHWAY
BIOCARTA_NFKB_PATHWAY
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
BIOCARTA_DEATH_PATHWAY
BIOCARTA_HIVNEF_PATHWAY
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
BIOCARTA_TNFR2_PATHWAY
BIOCARTA_MITOCHONDRIA_PATHWAY
BIOCARTA_CASPASE_PATHWAY
BIOCARTA_STRESS_PATHWAY
REACTOME_APOPTOSIS
BIOCARTA_TOLL_PATHWAY
REACTOME_GENES_INVOLVED_IN_APOPTOTIC_CLEAVAGE_OF_CELLULAR_
PROTEINS
REACTOME_APOPTOTIC_EXECUTION_PHASE
KEGG_MAPK_SIGNALING_PATHWAY
KEGG_SMALL_CELL_LUNG_CANCER
REACTOME_TOLL_RECEPTOR_CASCADES
Table 2.  Topological and biological properties of early and late proteins characterized by confidence level 
criterion (c): FC > 1.5 and p-value < 0.05.
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For this analysis we used a modified z-score > 1.6 defined by39:
=
. − M x x
MAD
0 6745( ) , (1)i
i
where, MAD is the median absolute deviation and x denotes the median.
Human Interactome. We only consider direct physical interactions among molecular components with 
reported experimental evidence. For this purpose, we consolidated several data sources including regulatory 
interactions40; binary interactions containing high-throughput datasets41–44 with binary interactions from 
IntAct45 and MINT46 databases; literature-curated interactions from IntAct, MINT, BioGRID47, and HPRD48; 
metabolic enzyme-coupled interactions49; protein complexes50; kinase network51; signaling interactions52; and 
liver-specific interactions53. The resulting network has a power-law degree distribution54. For more information, 
see Supplementary Material.
Genetic Association. Genotype data for candidate functional genetic polymorphisms were collected in the 
Women’s Genome Health Study (WGHS)55 using the Human Exome BeadChip platform v.1.1 (Illumina, San 
Diego) and reduced to genotype calls as described56. We have used this data set as it is derived from the largest 
genome-wide study available to us. The genetic markers on this platform predominantly cause non-synonymous 
substitutions, splice site disruptions, or other known functional changes allowing relatively unambiguous assign-
ment to genes that are affected by their molecular consequences. In total, there were 22,516, 22,390 and 22,411 
WGHS participants of verified European ancestry with genotype data and plasma measures of C-reactive protein 
(CRP), sICAM1, and fibrinogen respectively. Similarly, there were 526 cases of incident venous thromboembo-
lism (VTE) compared with 21,479 unaffected WGHS participants with genotype data. SNPs were tested for asso-
ciation using linear (plasma biomarkers, log-transformed and residualized for age and population eigenvectors, if 
needed) or age- and eigenvector-adjusted logistic (VTE) regression. For each gene, a gene-wide p-value corrected 
for multiple testing was computed by the Šidák method applied to the minimum p-value among the SNPs map-
ping to each gene and having minor allele frequency of at least 0.0005.
LCC significance. The significance of the clustering of a given set of nodes is obtained by comparing the 
observed LCC size with the size expected for randomly distributed nodes of a set of the same size obtained from 
106 simulations. The resulting z-score is defined:
σ
− =
− < >z score lcc lcc
(2)
observed randomized
randomized
where lcc is the size of largest connected component, and < lcc>randomized and σ are the average size and standard 
deviation, respectively, of the largest connected components across all randomized sets.
Significance of module overlap. Part of the high overlap of the modules stems from common seed genes 
in the three endophenotypes. Considering that the seed genes represent established knowledge, calculating the 
significance of the module overlap reduced to calculating the significance of the overlap between the added 
(DIAMOnD) genes. We calculate the significance of inflammasome and thrombosome overlap using the follow-
ing methods:
(a)  First, we consider that 450 (700) detected DIAMOnD nodes with respect to inflammation (thrombosis) could 
have been selected from any nodes in the network. We calculate the p-value using Fisher’s exact test, resulting 
in a p-value < 10−324.
(b)  In practice, the detected nodes cannot be selected from anywhere in the network. Rather, they are iteratively 
added based on their connectivity patterns to seed nodes. To factor this principle into the analysis, we assume 
that detected nodes can be selected from first neighbors of seeds only. We further limit this pool of candidate 
nodes by taking those that are first neighbors of both inflammation and thrombosis seeds. This selection 
process will underestimate the resulting significance. Fisher’s exact test yields a p-value < 10−324.
(c)  With the same approach, we found the overlapping significance of p-value < 10−324 for both inflammas-
ome-thrombosome, and thrombosome-fibrosome pairs, respectively.
Biological validation and module size estimation. We used Gene Ontology and MSIgDB57 pathways 
as follows:
(a)  MSIgDB pathways: From the MSIgDB database, we retrieved the biological pathways significantly enriched 
with seed genes (FDR corrected). Next, we show that these pathways are also statistically highly enriched with 
DIAMonD genes. Figure 2 shows the number of DIAMOnD genes that belong to these sets of pathways as a 
function of DIAMOnD iteration and their corresponding p-values.
(b)  Gene Ontology (GO): In the same fashion, we extracted GO terms [http://www.geneontology.org/, down-
loaded April, 2016] significantly annotated for the seed genes and show that DIAMonD genes are significantly 
annotated for the same GO terms.
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Pathway enrichment. We performed pathway enrichment analysis for four different regions: (a) inflam-
masome, (b) thrombosome, (c) fibrosome, and (d) crosstalk. Supplementary Table 1 shows fully embedded path-
ways in specific regions of the modules.
Tree analysis. To assess whether a given set of nodes is essential for the integrity of the network, we remove 
them from the network and measure two parameters: (a) the number of remaining connected components 
(islands), and (b) the size of the remaining LCC. Next, we compare the results to expected values of these meas-
ures as follows:
(a) Randomly select the same number of nodes from the network.
(b) Remove these nodes from the network.
(c) Measure parameters as introduced above (a and b).
(d) Repeat steps (a–c) 106 times to produce a randomized distribution.
(e) Calculate a z-score for the actual observation.
Highly positive (negative) z-scores of the LCC size (number of connected components) reflect a central loca-
tion of the respective nodes. A group of nodes whose removal results in a significantly higher number of con-
nected components (z-score(CC) > 1.6) with a much smaller LCC (z-score(LCC) < − 1.6) is considered essential 
for the integrity of the HI, i.e., is trunk-like. By contrast, nodes whose removal leads to a significantly decreased 
number of connected components (z-score(CC) < − 1.6) and a larger LCC (z-score(LCC) > 1.6) are considered 
non-essential, i.e., are leaf-like (Supplementary Fig. 4).
As we compare the observed lcc size to over 105 randomizations, the randomized pool distribution approaches 
a normal distribution and, thus, using a z-score is a sensible choice for calculating the significance of deviation 
from a random distribution. In a normal distribution, a z-score of 1.6 is equivalent to a p-value of 0.05, a widely 
used significance threshold. Importantly, although we use a threshold of 1.6 for z-score significance, our results 
show that the z-scores associated with clustering of the inflammation, thrombosis, and fibrosis seed genes are 
10.85, 19.25, and 22.27, respectively. Thus, setting an even more stringent threshold would also confirm the sig-
nificance of the observed lcc.
Cardiovascular risk and differentially expressed genes. We used gene expression data derived from 
the population-based Gutenberg Health Study (GHS). The dataset consists of mRNA counts of the Illumina 
HT-12 v3 BeadChips (n = 1,285). Analyses were conducted at the University Heart Center, Hamburg, Germany.
We analyzed the data to retrieve differentially expressed genes associated with cardiovascular risk factors. The 
sample sizes were selected so that the biomarker levels are consistent with the recommended effect size (low and 
high risk ranges) from the literature58–60. Therefore, we defined cases and controls as individuals with the top and 
bottom 25% of the risk factor level distribution. The case and control sample sizes are listed in Supplementary 
Table 8. To derive the differentially expressed genes, we performed a non-parametric Mann-Whitney U-test. 
Supplementary Fig. 3 shows the Venn diagram of differentially expressed genes with respect to different risk 
factors.
We showed that the inflammation, thrombosis, and fibrosis gene (networks) are significantly enriched with 
differentially expressed genes of CRP, HDL-C, APO-A, and triglyceride modules. There were only 9 and 3 dif-
ferentially expressed genes associated with APO-B and LDL-C. Therefore, due to lack of statistical power, we 
observed non-significant enrichment of module proteins with those genes. Surprisingly, neither the seeds nor 
detected modules were enriched with fibrinogen genes.
THP-1 cell culture experiments and proteomics. We first treated the human monocytoid cell line 
THP-1 with PMA for 48 hours to promote their differentiation into macrophage-like cells. As the specific molec-
ular mechanisms by which INFγ promotes M1 responses (e.g., pro-inflammatory cytokine production) have been 
extensively studied, we chose INFγ as the M1-polarizing activated macrophage stimulus. Supplementary Fig. 6 
demonstrates that INFγ treatment in THP-1 cells induced the potent pro-inflammatory molecules, TNFα and 
IL-1β , commonly used as markers of M1 activated macrophages. THP-1 cells (ATCC) were then incubated with-
out (M0) or with 10 ng/ml INFγ for 72 hours (M1). Cells were collected from each time course condition at six 
time points –0, 8, 12, 24, 48 and 72 hours –for subsequent protein isolation, proteolysis, fractionation using isoe-
letric focusing (OFF-gel, Agilent)61,62 and tandem mass tagging [TMT-6plex, Pierce] as described previously63. 
The peptides were analyzed by an LTQ-Orbitrap Elite model (Thermo Scientific) coupled to an Easy-nLC1000 
HPLC pump (Thermo Scientific). The top 20 precursor ions (within a scan range of 380–2000 m/z, resolution set 
to 120 K) were subjected to higher energy collision-induced dissociation (HCD, collision energy 40%, isolation 
width 3 m/z, dynamic exclusion enabled, and resolution set to 30 K) for peptide sequencing (MS/MS). The MS/
MS data were queried against the human Uniprot database (downloaded on March 27, 2012) using the SEQUEST 
search algorithm via the Proteome Discoverer (PD) Software package (version 1.3, Thermo Scientific) using a 10 
ppm tolerance window in the MS1 search space, and a 0.02 Da fragment tolerance window for HCD. Methionine 
oxidation and 6-plex TMT tags (Thermo Scientific) were set as variable modifications, and carbamidomethylation 
of cysteine residues was set as fixed modification. The peptide false discovery rate (FDR) was calculated using 
Percolator provided by PD: the FDR was determined based on the number of MS/MS spectral hits when searched 
against the reverse, decoy human database64,65. Peptides were filtered based on a 1% FDR. Peptides assigned to a 
given protein group, and not present in any other protein group, were considered as unique and quantified for the 
protein (PD Grouping feature).
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Proteomic analysis revealed that 4,680 (4,589) proteins were detected (with at least 2 unique peptide ID and a 
unique gene ID) in the M0 (M1) condition, among which 4,278 (4,188) proteins were found to have at least one 
interacting partner in the consolidated HI.
In order to explore protein abundance changes in response to inflammatory stimuli, we restricted our study 
to the proteins whose levels were measured in both M0 and M1 conditions. We found that of the 4,143 proteins 
found in both datasets, 447 reside within the detected endophenotype modules (p-value = 1.13 × 10−9).
Next, we observed that the M0 and M1 proteins residing in the endophenotype modules (ome-M proteins) 
are functionally and significantly different from those outside of the module. To do so we proceeded as follows:
(a) We store the pathways enriched by ome-M proteins in a pathway array = …P P P[ , , ]0 1
0
2
0 .
(b) From all proteins detected in M0 and M1 condition, we randomly select the same number of ome-M proteins.
(c) We store the pathways enriched by these randomly selected proteins in = …P P P[ , , ]1 1
1
2
1 .
(d) We repeat steps (b) and (c) 1000 times to find …P P P, ,1 2 1000enriched pathway arrays.
(e) We calculate the Jaccard similarity of all pairwise combinations of the 1000 pathway arrays.
(f) Next, we calculate the Jaccard similarity of P0 with every of the 1000 pathway arrays.
The distribution of Jaccard similarities calculated in step (e) and (f) are shown in gray and red respectively in 
Supplementary Fig. 5. Our observation shows that detected proteins that reside in the modules functionally and 
significantly differ from other detected proteins outside the modules. Therefore, we limit our further studies to 
these ome-M proteins.
To identify the early and late proteins within the ome-M proteins, we have studied the average FC of protein 
abundance before and after 24 hrs. As the FC threshold is an arbitrary choice, we have included three levels of 
confidence for identifying early and late proteins. The criteria for these three levels of confidence include: (a) 
p-value < 0.05, (b) FC > 1.5, and (c) p-value < 0.05 and FC > 1.5. Table 2 shows the early and late proteins identi-
fied by the most stringent criterion (c).
Clustering Analysis and visualization. For performing k-means clustering, we used Cluster 3.0, and for 
viewing the heatmap, we used Java TreeView.
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